Geron Corporation ( GERN ) announced that it has signed an Asset Contribution Agreement with BioTime, Inc. ( BTX ) and BioTime’s recently formed subsidiary, BioTime Acquisition
View original post here:
Geron’s Update on Stem Cell Assets – Analyst Blog